CD40LG and myeloid sarcoma: These findings suggest a potential impairment in the IgM-specific humoral response to dsRNA in MS, which may hinder effective clearance of immunostimulatory dsRNA structures following viral infection, thereby contributing to sustained inflammation in MS pathogenesis.